Takeyama K | National Cancer Center Hospital Tokyo Jpn
スポンサーリンク
概要
関連著者
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
WATANABE Takashi
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
KUSHIRO Toshio
Nihon University
-
三木 義男
癌研ゲノムセンター
-
KOBAYASHI Yukio
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
Maruyama Dai
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
Mizuno Kyoichi
日本医科大学 内科学
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
喜多 義邦
Division Of Preventive Cardiology National Cardiovascular Center
-
KIM Sung-Won
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
NAKATA Masanobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HOTTA Tomomitsu
Department of Hematology and Oncology, Tokai University School of Medicine
-
GONDO Hisashi
Department of Internal Medicine, Saga Prefectural Hospital Koseikan
-
Horiguchi Hiromasa
Health Management And Policy University Of Tokyo Graduate School Of Medicine
-
Kuwabara Kazuaki
Dep. Of Health Care Administration And Management Kyushu Univ. Graduate School Of Medical Sciences
-
Kuwabara Kazuaki
Department Of Health Care Administration And Management Kyushu University
-
Mizuno Kyoichi
Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine
-
Matsuda Koichi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
YOKOYAMA Hiroki
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
Mizuno Kyoichi
First Department Of Internal Medicine Nippon Medical School
-
OHASHI Kazuteru
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
Matsuda Shinya
Department of Preventive Medicine and Community Health, University of Occupational and Environmental
-
KAMIMURA Tomohiko
Department of Hematology, Harasanshin General Hospital
-
荻原 俊男
Division Of Preventive Cardiology National Cardiovascular Center
-
荻原 俊男
大阪大学医学部・老年・腎臓内科
-
SHIMADA Kazuyuki
Department of Medicine, Jichi Medical University
-
谷脇 雅文
高知工科大学工学部
-
MIYAGI MAESHIMA
Clinical Laboratory, National Cancer Center Hospital
-
MATSUNO Yoshihiro
Department of Surgical Pathology, Hokkaido University Hospital
-
高橋 宏和
佐賀大学医学部内科
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
KAWANO Fumio
Department of Internal Medicine, National Hospital Organization, Kumamoto Medical Center
-
ETO Tetsuya
Department of Hematology, Hamanomachi Hospital
-
MORIUCHI Yukiyoshi
Department of Hematology, Sasebo City General Hospital
-
HIGUCHI Masakazu
Department of Internal Medicine, Kyushu Kosei-nenkin Hospital
-
OKAMURA Takashi
Division of Hematology, Department of Medicine, Kurume University School of Medicine
-
Kasumi Fujio
Department of Surgery and Pathology, Cancer Institute Hospital
-
ANDO Kiyoshi
Department of Hematology/Oncology, Tokai University School of Medicine
-
Muratani H
Department Of Clinical Pharmacology And Therapeutics Tohoku University
-
Muramatsu Toshiya
behalf of the j-Cypher Registry Investigators
-
MORI Shinichiro
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
Yamada Y
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Yamada Yasuaki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
NOMOTO Junko
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
Yamada Y
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
高橋 宏知
東京大学 先端科学技術研究センター・生命知能システム
-
Hori Masatsugu
大阪大学 医学系研究科循環器内科学
-
YOSHINO Tadashi
Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica
-
Horiguchi Hiromasa
Department of Health Management and Policy, Graduate School of Medicine, The University of Tokyo
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
OHNO Ryuzo
Aichi Cancer Center
-
OKUMURA Hirokazu
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
SEKI Ritsuko
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
OHSHIMA Koichi
Department of Pathology, Kurume University School of Medicine
-
FUJISAKI Tomoaki
Department of Internal Medicine, Matsuyama Red Cross Hospital
-
MAKINO Shigeyoshi
Department of Internal Medicine, Miyazaki Prefectural Hospital
-
TAGUCHI Fumihiro
Department of Hematology, Iizuka Hospital
-
TSUDA Hiroyuki
Division of Clinical Hematology, Kumamoto City Hospital
-
OGAWA Ryosuke
Shimonoseki City Central Hospital
-
SHIMODA Kazuya
Department of Internal Medicine, Gastroenterology and Hematology, Faculty of Medicine, Miyazaki Univ
-
YAMASHITA Kiyoshi
Department of Internal Medicine, Gastroenterology and Hematology, Faculty of Medicine, Miyazaki Univ
-
SUZUKI Keiko
Department of Internal Medicine, Koga General Hospital
-
SUZUSHIMA Hitoshi
Department of Internal Medicine, NTT Nishinippon Kyushu General Hospital
-
TSUKAZAKI Kunihiro
Molecular Medicine Unit and Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate
-
UTSUNOMIYA Atae
Department of Hematology, Imamura Bun-in Hospital
-
IWAHASHI Masahiro
Department of Internal Medicine, Saiseikai-Hita Hospital
-
IMAMURA Yutaka
Department of Hematology, St. Mary Hospital
-
TAMURA Kazuo
Division of Medical Oncology and Hematology, Department of Medicine, Fukuoka University Hospital
-
SUZUMIYA Junji
Department of Internal Medicine, Fukuoka University Chikushi Hospital
-
YOSHIDA Minoru
Japanese Red Cross Kumamoto Health Care Center
-
ABE Yasunobu
Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu Univers
-
MATSUMOTO Tadashi
Department of Hematology, Imamura Hon-in Hospital
-
Sakamoto Goi
Department of Surgery and Pathology, Cancer Institute Hospital
-
KUWABARA KAZUAKI
Department of Health Care Administration and Management, Kyushu University
-
FUJIMORI KENJI
Division of Medical Management, Hokkaido University
-
北 徹
Department Of Geriatric Medicine Osaka University Graduate School Of Medicine
-
北 徹
京都大学大学院医学研究科循環器内科学
-
北 徹
京都大学老年科
-
WAKAI Kenji
Department of Clinical Epidemiology, University of Occupational and Environmental Health
-
UESHIMA Hirotsugu
Shiga University of Medical Science
-
KATSUYA Tomohiro
Osaka University
-
Kohara Katsuhiko
Department Of Cardiovascular Medicine Nephrology And Neurology Faculty Of Medicine And Dialysis Unit
-
Kikuchi Kenjiro
Second Department Of Internal Medicine Sapporo Medical College
-
Suzuki Tatsuya
Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University
-
Kaikita Koichi
Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kumamoto University
-
Kita Toru
京都大学 医学研究科循環器内科学
-
Yamada Yasuaki
富山大学 工学部
-
Yoshida S
Chiba University
-
TANIGUCHI Hirokazu
Clinical Laboratory, National Cancer Center Hospital
-
HEIKE Yuji
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
YAMASAKI Satoshi
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
TAJI Hirofumi
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
HASHIMOTO Shuji
Department of Physiologic Laboratory, National Cardiovascular Center
-
KAKIHANA Kazuhiko
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
NAKAI Toshiko
Division of Cardiology, Department of Medicine, Nihon University School of Medicine
-
上平 憲
長崎大学医学部附属病院検査部
-
MUROHARA Toyoaki
Department of Cardiology, Nagoya University Graduate School of Medicine
-
小林 由実
佐賀大学代謝内分泌内科
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
OHTAKE Shigeki
Department of Hematology, Kanazawa University Graduate School of Medical Science
-
KIYOI Hitoshi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
TAKEUCHI Jin
Department of Hematology and Rheumatology, Nihon University School of Medicine
-
KAGEYAMA Shinichi
Department of Hematology and Oncology, Mie University Graduate School of Medicine
-
NAGAFUJI Koji
Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine
-
MITANI Kinuko
Department of Hematology, Dokkyo University School of Medicine
-
OGAWA Yoshiaki
Department of Hematology and Oncology, Tokai University School of Medicine
-
Yasujima Minoru
Kobe University
-
Tomino Y
Department Of Basic Medical Research And Education Ehime University Graduate School Of Medicine
-
永井 正
自治医科大学内科学講座血液学部門
-
ANDO KOJI
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
-
佐藤 洋
東北大学大学院医学系研究科環境保健医学
-
Miyazawa Keisuke
Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ
-
OZASA Kotaro
Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medici
-
ITO Yoshinori
Department of Public Health, Fujita Health University School of Health Sciences
-
TAMAKOSHI Akiko
Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Gradu
-
IMAI Yutaka
Tohoku University
-
KAWANO Yuhei
National Cardiovascular Center
-
UMEMURA Satoshi
Yokohama City University
-
HIRAWA Nobuhito
Yokohama City University
-
TSUBAKIHARA Yoshiharu
Osaka General Medical Center
-
HIRAWA Nobuhito
Department of Internal Medicine and Cardiorenal Medicine Yokohama City University Graduate School of
-
Hoshikawa Yoshiko
Div. Of Molecular And Genetic Medicine Dep. Of Genetic Medicine And Regenerative Therapeutics Gradua
-
Kohno Shigeru
長崎大学 医学部第二内科
-
Kohno S
Second Dep. Of Internal Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ
-
Kohno Shigeru
佐世保市立総合病院
-
Umemura S
University Of The Ryukyus
-
Umemura Satoshi
熊本大学 医学薬学研究部循環器病態学
-
Nozawa Takashi
Second Department Of Internal Medicine Graduate School Of Medicine University Of Toyama
-
Sasano H
Tohoku University 21st Century Coe Program 'comprehensive Research And Education Center For Pla
-
Takishita S
University Of The Ryukyus
-
METOKI Hirohito
Department of Clinical Pharmacology and Therapeutics, Tohoku University
-
OHKUBO Takayoshi
Department of Planning for Drug Development and Clinical Evaluation, Tohoku University
-
KIKUYA Masahiro
Department of Clinical Pharmacology and Therapeutics, Tohoku University
-
ASAYAMA Kei
Department of Planning for Drug Development and Clinical Evaluation, Tohoku University
-
HARA Azusa
Department of Clinical Pharmacology and Therapeutics, Tohoku University
-
TOTSUNE Kazuhito
Department of Clinical Pharmacology and Therapeutics, Tohoku University
-
MIKI Tetsuro
Department of Geriatric Medicine, Ehime University Graduate School of Medicine
-
IMAI Yutaka
Department of Clinical Pharmacology and Therapeutics, Tohoku University
-
OKAYAMA Akira
The First Institute for Health Promotion and Health Care, Japan Anti-tuberculosis Association
-
YOSHIMURA Takesumi
Fukuoka Institute of Health and Environmental Sciences
-
SUZUKI Yoshihiko
Suzuki clinic
-
坂本 弘明
Department of Internal Medicine II, Fukushima Medical University, School of Medicine
-
OHKUBO Takayoshi
Tohoku University 21st Century COE Program 'Comprehensive Research and Education Center for Planning
-
KANNO Atsuhiro
Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceu
-
Nakamura Hideo
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Kato Harumi
Department of Cardiology, Kurashiki Central Hospital
-
Hirakata Yoichi
長崎大学 医学部第二内科学
-
Tsukamoto Norifumi
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine
-
NAKAO Shinji
Department of Cellular Transplantation Biology, Graduate School of Medical Sciences, Kanazawa Univer
-
MURAYAMA Tohru
Department of Hematology, Hyogo Medical Center for Adults
-
TAKAUE Yoichi
Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital
-
森田 えみ
名古屋大学大学院医学系研究科
-
森田 えみ
名古屋大学大学院医学系研究科予防医学/医学推計・判断学
-
Kamihira Shimeru
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
上平 憲
長崎大学臨床検査医学
-
Hiro Takafumi
Departments Of Internal Medicine And Cardiology Osaka City University Graduate School Of Medicine
-
Sugahara Kazuyuki
Dep. Of Lab. Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ. Hospital
-
Sugahara Kazuyuki
長崎大学 医歯薬学総合研究科臨床検査医学講座
-
佐藤 洋
東北大学大学院医学系研究科環境保健医学分野
-
NAGASE Kumiko
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
TAKAHASHI Noriko
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
WAKI Fusako
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
AIZAWA Shin
Department of Functional Morphology, Nihon University School of Medicine
-
OMATSU Mutsuko
Clinical Laboratory, National Cancer Center Hospital
-
ONO Makiko
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
SHIBATA Tsuyoshi
Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
-
MIKAMI Yuzuru
Medical Mycology Research Center (MMRC), Chiba University
-
TSUCHIYA Takahide
Department of Hematology and Oncology, Tokai University School of Medicine
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Nozawa Takashi
富山大学 医学薬学研究部第2内科
-
Itoh Hiroaki
Osaka City University
-
Itoh Hiroshi
First Pathology Faculty Of Medical Sciences University Of Fukui
-
Itoh Hiroshi
Division Of Surgical Pathology Department Of Biomedical Informatics Kobe University Graduate School
-
Itoh Hiroshi
宮崎大学 医学部病理学第2
-
Itoh Hiroshi
Division 1 Department Of Pathology Kobe University School Of Medicine
-
上平 憲
長崎大学大学院 臨床検査医学
-
Kawakami S
Santen Pharmaceutical Co. Ltd. Nara Research And Development Center:department Of Hospital Pharmacy
-
Kawakami Shigeru
京都大学 薬学研究科
-
Kawakami Shigeru
Dep. Of Drug Delivery Res. Graduate School Of Pharmaceutical Sciences Kyoto Univ.
-
Tsutsumi Yoshiaki
Genetics Division National Cancer Center Research Institute
-
Tsutsumi Yoshiaki
国立循環器病センター
-
MURATE Takashi
Nagoya University School of Health Sciences
著作論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Bacterial Bloodstream Infection in Neutropenic Adult Patients after Myeloablative Cord Blood Transplantation : Experience of a Single Institution in Japan
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- 1P345 NMRメタボロミクスの医療への応用 : 透析患者血漿と廃液の解析(その他,第48回日本生物物理学会年会)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
- Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma : Japan Clinical Oncology Group study 9004
- A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
- Diagnostic Mammography and Ultrasonography for Palpable and Nonpalpable Breast Cancer in Women Aged 30 to 39 Years
- Diagnostic Ultrasonography and Mammography for Invasive and Noninvasive Breast Cancer in Women Aged 30 to 39 Years
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Paroxysmal Nocturnal Hemoglobinuria
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- The Decrease in Average Years of Life Lost Due to Breast Cancer in Japan during the Period from 1995 to 2006
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
- 58. Health care system in Vietnam : current situation and challenges
- Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease : the Ohasama study
- Inhibitory Effect of AL-3264, a New Antiallergic Agent, on the Prausnitz-Kustner Reaction and Leukotriene Production in Monkeys
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Impact of Smoking and Other Lifestyle Factors on Life Expectancy among Japanese : Findings from the Japan Collaborative Cohort (JACC) Study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women
- Rationale and design of the NAGOYA HEART Study : Comparison between valsartan and amlodipine regarding morbidity and mortality in patients with hypertension and glucose intolerance
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Profiling of the Care Processes for Laryngeal Cancer with the Japanese Administrative Database
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Equivalent Clinical Outcomes of Bleeding Peptic Ulcers in Teaching and Non-Teaching Hospitals : Evidence for Standardization of Medical Care in Japan
- In Vitro Effects of Recombinant Human IL-11 on Human Malignant Lymphoma Cells
- Evaluation of compliance with the Tokyo Guidelines for the management of acute cholangitis based on the Japanese administrative database associated with the Diagnosis Procedure Combination system
- Decreased expression of adrenomedullin 2/intermedin in the kidney of hypertension or renal failure ; Possible involvement in chronic kidney disease
- Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
- Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C
- The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Association Between Dietary Pattern and Serum C-Reactive Protein in Japanese Men and Women
- A descriptive study evaluating the circumstances of medical treatment for acute pancreatitis before publication of the new JPN guidelines based on the Japanese administrative database associated with the Diagnosis Procedure Combination system
- Disability-Adjusted Life Years (DALY) for Cancer in Japan in 2000
- An Association Between Long-Term Exposure to Ambient Air Pollution and Mortality From Lung Cancer and Respiratory Diseases in Japan
- Seropositivity for Anti-HCV Core Antigen is Independently Associated With Increased All-Cause, Cardiovascular, and Liver Disease-Related Mortality in Hemodialysis Patients
- Body Mass Index and Mortality From All Causes and Major Causes in Japanese : Results of a Pooled Analysis of 7 Large-Scale Cohort Studies
- Weight Gain During Adulthood and Body Weight at Age 20 Are Associated With the Risk of Endometrial Cancer in Japanese Women
- Comparison of axial force and cell width of self-expandable metallic stents : which type of stent is better suited for hilar biliary strictures?
- Optimal cutoff values of waist circumference and the discriminatory performance of other anthropometric indices to detect the clustering of cardiovascular risk factors for metabolic syndrome in Japanese men and women
- Smoking and Smoking Cessation in Relation to All-Cause Mortality and Cardiovascular Events in 25,464 Healthy Male Japanese Workers
- Profile of Participants and Genotype Distributions of 108 Polymorphisms in a Cross-Sectional Study of Associations of Genotypes With Lifestyle and Clinical Factors : A Project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Influence of adrenomedullin 2/intermedin gene polymorphism on blood pressure, renal function and silent cerebrovascular lesions in Japanese : the Ohasama study
- Genetic Polymorphisms of XRCC1, Alcohol Consumption, and the Risk of Colorectal Cancer in Japan
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Impact of Low Levels of Vascular Endothelial Growth Factor After Myocardial Infarction on 6-Month Clinical Outcome : Results From the Nagoya Acute Myocardial Infarction Study
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Is Magnetic Resonance Imaging of Right Ventricular Volume Useful Clinically for Evaluation of Pulmonary Arterial Hypertension?
- Age-Period-Cohort Analysis of Chronic Obstructive Pulmonary Disease Mortality in Japan, 1950-2004
- Industry-based retrospective cohort study of the risk of prostate cancer among rotating-shift workers
- Quality of life after laparoscopy-assisted pylorus-preserving gastrectomy : an evaluation using a questionnaire mailed to the patients
- The Significance of Measuring Body Fat Percentage Determined by Bioelectrical Impedance Analysis for Detecting Subjects With Cardiovascular Disease Risk Factors
- Hunting for genes for hypertension : the Millennium Genome Project for Hypertension
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95
- Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery
- The Care Processes for Acute Cholecystitis According to Clinical Practice Guidelines Based on the Japanese Administrative Database
- Biotin Ameliorates Muscle Cramps of Hemodialysis Patients : A Prospective Trial